Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

Stratview Research, a global market research firm, has launched a report on the global eVTOL market, which provides a comprehensive outlook of the global and regional industry forecast, current & ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Research on the insectome in and around broiler breeder pullet farms has identified new potential vectors of Histomonas ...

NYSE: EVTL], a global aerospace and technology company that is pioneering electric aviation, is today announcing the appointment of Paul Stone as a Test Pilot. His arrival makes Vertical one of the ...

Labtician Ophthalmics, Inc. is proud to announce the launch of LabtmTRIACTIV, a transformative artificial tear designed to redefine dry eye relief. Powered by advanced cationic liposomal technology, ...

Lucid Diagnostics Inc.  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. , today announced a campaign, entitled "Embrace the ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full ...

They're coming back - not that they've ever been away for long. But it would be prudent not to get too carried away just yet, as a new dawn has beckoned for airships many times over the years without ...

The Parainfluenza Virus Infection market is expected to surge due to the disease's increasing prevalence and awareness during ...

Viral-vectored vaccines can be designed quickly. One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster shots need to be given.